259 related articles for article (PubMed ID: 23897660)
1. Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice.
Coulson-Thomas VJ; Caterson B; Kao WW
Stem Cells; 2013 Oct; 31(10):2116-26. PubMed ID: 23897660
[TBL] [Abstract][Full Text] [Related]
2. Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.
Serratrice N; Cubizolle A; Ibanes S; Mestre-Francés N; Bayo-Puxan N; Creyssels S; Gennetier A; Bernex F; Verdier JM; Haskins ME; Couderc G; Malecaze F; Kalatzis V; Kremer EJ
J Control Release; 2014 May; 181():22-31. PubMed ID: 24607662
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity.
Call M; Elzarka M; Kunesh M; Hura N; Birk DE; Kao WW
Mol Vis; 2019; 25():415-426. PubMed ID: 31523119
[TBL] [Abstract][Full Text] [Related]
4. Umbilical mesenchymal stem cell-derived extracellular vesicles as enzyme delivery vehicle to treat Morquio A fibroblasts.
Flanagan M; Pathak I; Gan Q; Winter L; Emnet R; Akel S; Montaño AM
Stem Cell Res Ther; 2021 May; 12(1):276. PubMed ID: 33957983
[TBL] [Abstract][Full Text] [Related]
5. Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII.
Cadaoas J; Boyle G; Jungles S; Cullen S; Vellard M; Grubb JH; Jurecka A; Sly W; Kakkis E
Mol Genet Metab; 2020 May; 130(1):65-76. PubMed ID: 32192868
[TBL] [Abstract][Full Text] [Related]
6. Umbilical cord mesenchymal stem cells suppress host rejection: the role of the glycocalyx.
Coulson-Thomas VJ; Gesteira TF; Hascall V; Kao W
J Biol Chem; 2014 Aug; 289(34):23465-81. PubMed ID: 24986866
[TBL] [Abstract][Full Text] [Related]
7. Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice.
Liu H; Zhang J; Liu CY; Wang IJ; Sieber M; Chang J; Jester JV; Kao WW
PLoS One; 2010 May; 5(5):e10707. PubMed ID: 20502663
[TBL] [Abstract][Full Text] [Related]
8. Self-complementary AAV vector therapy for treating corneal cloudiness of mucopolysaccharidosis type VII (MPS VII).
Venkatakrishnan J; Yuan Y; Zhang J; Yu Y; Hu YC; Kao WW
Ocul Surf; 2024 Apr; 32():39-47. PubMed ID: 38218582
[TBL] [Abstract][Full Text] [Related]
9. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons.
Bayó-Puxan N; Terrasso AP; Creyssels S; Simão D; Begon-Pescia C; Lavigne M; Salinas S; Bernex F; Bosch A; Kalatzis V; Levade T; Cuervo AM; Lory P; Consiglio A; Brito C; Kremer EJ
Sci Rep; 2018 Nov; 8(1):16644. PubMed ID: 30413728
[TBL] [Abstract][Full Text] [Related]
11. Large proteoglycan complexes and disturbed collagen architecture in the corneal extracellular matrix of mucopolysaccharidosis type VII (Sly syndrome).
Young RD; Liskova P; Pinali C; Palka BP; Palos M; Jirsova K; Hrdlickova E; Tesarova M; Elleder M; Zeman J; Meek KM; Knupp C; Quantock AJ
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6720-8. PubMed ID: 21743015
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of vestronidase alfa enzyme replacement therapy in pediatric subjects < 5 years with mucopolysaccharidosis VII.
Lau HA; Viskochil D; Tanpaiboon P; Lopez AG; Martins E; Taylor J; Malkus B; Zhang L; Jurecka A; Marsden D
Mol Genet Metab; 2022 May; 136(1):28-37. PubMed ID: 35331634
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of abnormal amounts of glycosaminoglycans in murine mucopolysaccharidosis type VII neural progenitor cells does not alter the growth rate or efficiency of differentiation into neurons.
Heuer GG; Skorupa AF; Prasad Alur RK; Jiang K; Wolfe JH
Mol Cell Neurosci; 2001 Jan; 17(1):167-78. PubMed ID: 11161477
[TBL] [Abstract][Full Text] [Related]
14. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-β/SMAD2 Pathway During Wound Healing.
Fang S; Xu C; Zhang Y; Xue C; Yang C; Bi H; Qian X; Wu M; Ji K; Zhao Y; Wang Y; Liu H; Xing X
Stem Cells Transl Med; 2016 Oct; 5(10):1425-1439. PubMed ID: 27388239
[TBL] [Abstract][Full Text] [Related]
15. Corneal endothelium in mucopolysaccharide storage disorders. Morphologic studies in animal models.
Mollard RJ; Telegan P; Haskins M; Aguirre G
Cornea; 1996 Jan; 15(1):25-34. PubMed ID: 8907377
[TBL] [Abstract][Full Text] [Related]
16. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
[TBL] [Abstract][Full Text] [Related]
17. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.
Hennig AK; Ogilvie JM; Ohlemiller KK; Timmers AM; Hauswirth WW; Sands MS
Mol Ther; 2004 Jul; 10(1):106-16. PubMed ID: 15233947
[TBL] [Abstract][Full Text] [Related]
18. Biological activity reduction and mitochondrial and lysosomal dysfunction of mesenchymal stem cells aging in vitro.
Zhang G; Wang Y; Lin J; Wang B; Mohsin A; Cheng Z; Hao W; Gao WQ; Xu H; Guo M
Stem Cell Res Ther; 2022 Aug; 13(1):411. PubMed ID: 35964126
[TBL] [Abstract][Full Text] [Related]
19. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
Richard M; Arfi A; Seguin J; Gandolphe C; Scherman D
Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
[TBL] [Abstract][Full Text] [Related]
20. Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.
Kantaputra PN; Smith LJ; Casal ML; Kuptanon C; Chang YC; Nampoothiri S; Paiyarom A; Veerasakulwong T; Trachoo O; Ketudat Cairns JR; Chinadet W; Tanpaiboon P
Am J Med Genet A; 2019 Mar; 179(3):486-493. PubMed ID: 30653816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
